| LONZA GROUP AG NA SF 1 |
| Schweiz |
| Gesundheit |
| CH0013841017 / 928619 |
| LO3 (Frankfurt) |
| FRA:LO3, ETR:LO3, LO3:GR |
| SMI |
| https://www.lonza.com/ |
|
Lonza Group AG is a Swiss-based global leader in contract development and manufacturing organization (CDMO) services for the pharmaceutical, biotech, and nutrition industries. Founded in 1897, it has evolved from electrochemical manufacturing and pow..
>Volltext.. |
| 39886.64 Mio. EUR |
| 44013.77 Mio. EUR |
| 7217.92 Mio. EUR |
| 2281.09 Mio. EUR |
| -303.92 Mio. EUR |
| -4.34 EUR |
| 4979.93 Mio. EUR |
| 794.62 Mio. EUR |
| 1291.95 Mio. EUR |
| 0.2 |
| 0.31% |
| -143.66% |
| 5.46 EUR |
| 0.93% |
| 0.93% |
| 12.05.26 - 5.4575005€ 13.05.25 - 2.1622€ >weitere anzeigen... |
| - |
| LONZA |
| 01.07.26 |
|
||||
|